AAM Sees Boon From Biden Order And CMS Biosimilar Action
US Generics And Biosimilars Industry Association Welcomes Latest Developments
The US Association for Accessible Medicines has welcomed an executive order from president Joe Biden aimed at lowering prescription drug costs, shortly after the AAM’s Biosimilars Council praised payment changes for biosimilars made by the Centers for Medicare & Medicaid Services.
